相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors
Xiao-Fei Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
Antony D. Abraham et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination
Katja Linher-Melville et al.
PLOS ONE (2020)
Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
Chen Xu et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2019)
Clinicians' Guide to Cannabidiol and Hemp Oils
Harrison J. VanDolah et al.
MAYO CLINIC PROCEEDINGS (2019)
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Wayne Hall et al.
LANCET (2019)
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits et al.
PAIN AND THERAPY (2019)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies
Emily Stockings et al.
PAIN (2018)
Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
L. Cunetti et al.
TRANSPLANTATION PROCEEDINGS (2018)
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model
Irina Cherniakov et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Cannabis constituent synergy in a mouse neuropathic pain model
Sherelle L. Casey et al.
PAIN (2017)
Pharmacokinetic and behavioural profile of THC, CBD, and THC plus CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC
Tomas Hlozek et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Single and combined effects of Δ9-tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain
Kirsten M. King et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity
Stevie C. Britch et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice
Hannah M. Harris et al.
PLANTA MEDICA (2016)
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
John Merrick et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Sara Jane Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments
Robert P. Bonin et al.
MOLECULAR PAIN (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
A new definition of neuropathic pain
Troels S. Jensen et al.
PAIN (2011)
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
Charlotte Klein et al.
PSYCHOPHARMACOLOGY (2011)
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
Cory C. Toth et al.
MOLECULAR PAIN (2010)
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
Robert H. Dworkin et al.
MAYO CLINIC PROCEEDINGS (2010)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
Kazuhide Hayakawa et al.
BRAIN RESEARCH (2008)
Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception
Jovan Williams et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
An overview of drug combination analysis with isobolograms
Ronald J. Tallarida
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Interactions between THC and cannabidiol in mouse models of cannabinoid activity
SA Varvel et al.
PSYCHOPHARMACOLOGY (2006)
Pharmacological characterization of the chronic constriction injury model of neuropathic pain
J De Vry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice
RJ Tallarida et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
分享论文
